R&D News | pharmaphorum

News

Expert 'optimistic' over COVID-19 vaccines after Moderna dat...

There are reasons to be optimistic over the cutting-edge mRNA vaccines being developed to end the COVID-19 pandemic, according to an expert in the field.

News

There are three types of white blood cells. T lymphocytes, B lymphocytes and natural killer cells.

Kadmon preps filing for GVHD drug belumosudil after phase 3 ...

New York biotech Kadmon is on course to file for FDA approval of belumosudil for chronic graft versus host disease (GVHD) after it hit the mark in a pivotal trial.

News

euro notes and tablets, symbol photo for costs of medicines and health insurance.

European VCs ‘actively seeking new healthcare investments’

The disruption caused by the coronavirus crisis hasn’t dampened the enthusiasm of European venture capitalists to make funding available to healthcare companies, says a ne

News

AZ scales up COVID-19 vaccine effort after $1bn US investmen...

AstraZeneca has said that it will be able to produce a billion doses of its potential COVID-19 vaccine by 2021 after receiving more than $1 billion from the US government to support develop

News

Gilead and Galapagos shares hit as filgotinib disappoints

Gilead and Galapagos' late-stage trial of their ulcerative colitis drug filgotinib has hit its target – but shares in both companies were down after data suggested the drug may struggle for

News

Blood sample with respiratory coronavirus positive

Biosig cleared to test merimepodib plus remdesivir in COVID-...

US biotech BioSig Technologies’ subsidiary ViralClear has been cleared by the FDA to start a phase 2 trial of its antiviral drug merimepodib in patients who are severely ill wi

Expert 'optimistic' over COVID-19 vaccines after Moderna dat...

Kadmon preps filing for GVHD drug belumosudil after phase 3 ...

European VCs ‘actively seeking new healthcare investments’

AZ scales up COVID-19 vaccine effort after $1bn US investmen...

Gilead and Galapagos shares hit as filgotinib disappoints

Biosig cleared to test merimepodib plus remdesivir in COVID-...

Lilly inflates US facility investment spending by $4.5bn

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks